A row of experts that advises a US Food and Drug Administration has urged stronger labeling on birth control pills such as Bayer's Yaz that have a shown a aloft risk of peck clots.
Results of a 21-5 opinion expelled late Thursday showed that many panel members found a stream labels did not sufficient simulate a risks and benefits.
The row was pided on a doubt of either a advantages of such pills transcend a risks, with 15 observant "yes" and 11 observant "no."
At emanate were pills that enclose drospirenone, that studies have found lift a aloft risk of blood clots than another form of progestin famous as levonorgestrel.
Some code names embody Yaz, Yasmin, Beyaz, Ocella, Loryna, Gianvi, Safyral, Syeda and Zarah.
Many have been marketed on a basement they assistance assuage premenstrual symptoms, revoke acne and means reduction weight benefit than competitors.
The pills have been a concentration of countless lawsuits, including one lodged progressing this year on interest of a teen who died from a blood clot allegedly related to a German chemical and curative association Bayer's Yaz contraceptive.
Two studies out this year in a British Medical Journal found that drugs like Yaz and Yasmin boost a risk of critical blood clots three-fold or two-fold compared to earlier-generation verbal contraceptives.
The central Yaz website says a drug is compared with "increased risks of several critical side effects, including blood clots, stroke, and heart attack."
The European Medicines Agency resolved on May 27 that such birth control pills lift a aloft risk of venous thromboembolism and that warning labels should be updated accordingly.
However, it remarkable a altogether risk of blood clot from any birth control process stays tiny and stopped brief of advising women to stop holding pills containing drospirenone.
Yaz is a second biggest offered product done by a German curative hulk Bayer, with $1.56 billion in tellurian sales.
The FDA does not have to follow a recommendation of a advisory row though it customarily does.
News referensi http://news.yahoo.com/us-panel-urges-stronger-labels-yaz-birth-control-153226571.html
0 comments:
Post a Comment